I graduated from Swansea University in 2016 with a first-class degree in Medical Genetics and received the Jim Parry award. During my studies, I completed an industrial year at GSK, honing skills in various genetic toxicology assays. I pursued a PhD at Swansea University, focusing on genotoxic endpoint analysis and assay development with high content imaging. Here, as PGR representative, I organised the medical school PGR conference, fostering a passion for scientific communication and engagement. My work at Helix3 in the USA involved the GLP comet assay to support regulatory submissions and feasibility assessment of investigative/mechanistic studies. Currently employed at GSK, I have expanded my knowledge of the drug development pipeline, DNA damage assays, benchmark dose analysis, and data handling. Alongside this, I support junior scientists and continue work on mode and mechanism of action with promising use of deep learning for mining of high content image data. A UKEMS member since 2014, I joined the NUKEMS committee in May 2022 and became chair in July 2023.